Heart and Lung Transplants from HCV-Infected Donors to Uninfected Recipients
Ann E. Woolley(Evidence (Italy)), Lindsey R. Baden(Brigham and Women's Hospital), John Fanikos(General Department of Preventive Medicine), Phillip C. Camp(Brigham and Women's Hospital), Amanda E. Kusztos(MACOM (United States)), Hilary J. Goldberg(Harvard University), Hari R. Mallidi(Brigham and Women's Hospital), Mandeep R. Mehra(Harvard University), Michael M. Givertz(Brigham and Women's Hospital), Kaiwen Chen(Brigham and Women's Hospital), Megan Johnson(MACOM (United States)), Steve K. Singh(Brigham and Women's Hospital), Antonio Coppolino(Brigham and Women's Hospital), David P. Harrington(MACOM (United States)), Esther Arbona Haddad(Brigham and Women's Hospital)
Cited by 324
Related Papers
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
|Science|2022|1.2k
Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis
|New England Journal of Medicine|2011|1.1k
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)
|Clinical Infectious Diseases|2020|1.1k
SARS-CoV-2 viral load is associated with increased disease severity and mortality
|Nature Communications|2020|981